Blog

Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen

Photo from Aaron Goodman/X

Feb 28, 2024, 12:20

Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen

Aaron Goodman recently shared a post on X/Twitter:

“Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen. Here it is described with other thyroid abnormalities with second-generation Tyrosine kinase inhibitors (TKIs).”

Read further.

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer Dasatinib dasatinib-induced hyperthyroidism National Comprehensive Cancer Network NHLs OncoDaily Oncology Tyrosine kinase inhibitors University of California San Diego

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage